Related Experiment Video
Updated: Jul 19, 2026

Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
Antiphospholipid syndrome and thrombosis
D Ware Branch1, Alexandra Grosvenor Eller
1University of Utah Health Sciences Center and Intermountain Healthcare, Salt Lake City, Utah 84132, USA. ware.branch@hsc.utah.edu
Antiphospholipid syndrome is an autoimmune disorder causing blood clots and adverse pregnancy outcomes. Diagnosis relies on identifying specific autoantibodies like lupus anticoagulant or anticardiolipin.
Area of Science:
- Immunology
- Hematology
- Obstetrics & Gynecology
Background:
- Antiphospholipid syndrome (APS) is an autoimmune condition.
- Characterized by recurrent thrombosis (venous or arterial) and/or pregnancy morbidity.
- Associated with specific autoantibodies.
Purpose of the Study:
- To define the key features and diagnostic markers of antiphospholipid syndrome.
- To highlight the clinical significance of APS in thrombosis and pregnancy.
Main Methods:
- Review of clinical and serological diagnostic criteria for APS.
- Identification of primary clinical manifestations and autoantibodies.
Main Results:
- Primary clinical features include venous/arterial thrombosis and adverse pregnancy outcomes.
- Adverse pregnancy outcomes encompass recurrent miscarriage, fetal death, and preterm delivery.
- Diagnostic autoantibodies are lupus anticoagulant, anticardiolipin, and anti-beta2-glycoprotein I.
Conclusions:
- Antiphospholipid syndrome is a significant autoimmune disorder with major clinical implications.
- Accurate diagnosis relies on a combination of clinical findings and specific autoantibody testing.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis I: Introduction
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism I: Introduction

